PubMed

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.

Torgerson JS, Hauptman J, Boldrin MN, Sjöström L.

Diabetes Care. 2004 Jan;27(1):155-61. Erratum in: Diabetes Care. 2004 Mar;27(3):856. PMID: 14693982 [PubMed - indexed for MEDLINE]Related articlesFree article

Analysis of the XENDOS study (Xenical in the Prevention of Diabetes in Obese Subjects).

Sjöström L.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:31-3. Review.PMID: 16627377 [PubMed - indexed for MEDLINE]Related articles

[Info-congress. Prevention of type 2 diabetes in obese patients: first results with orlistat in the XENDOS study]

Scheen AJ.

Rev Med Liege. 2002 Sep;57(9):617-21. French. PMID: 12440353 [PubMed - indexed for MEDLINE]Related articles

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J.

Diabetes Care. 1998 Aug;21(8):1288-94.PMID: 9702435 [PubMed - indexed for MEDLINE]Related articlesFree article

[Pharmacological therapy of obesity]

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.

Finer N, James WP, Kopelman PG, Lean ME, Williams G.

Int J Obes Relat Metab Disord. 2000 Mar;24(3):306-13.PMID: 10757623 [PubMed - indexed for MEDLINE]Related articles

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P.

Diabetes Care. 2002 Jun;25(6):1033-41. Erratum in: Diabetes Care. 2003 Mar;26(3):971.. PMID: 12032111 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.

Muls E, Kolanowski J, Scheen A, Van Gaal L; ObelHyx Study Group.

Int J Obes Relat Metab Disord. 2001 Nov;25(11):1713-21.PMID: 11753595 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults.

Heymsfield SB, Segal KR, Hauptman J, Lucas CP, Boldrin MN, Rissanen A, Wilding JP, Sjöström L.

Arch Intern Med. 2000 May 8;160(9):1321-6.PMID: 10809036 [PubMed - indexed for MEDLINE]Related articlesFree article

Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes.

Shi YF, Pan CY, Hill J, Gao Y.

Diabet Med. 2005 Dec;22(12):1737-43.PMID: 16401321 [PubMed - indexed for MEDLINE]Related articles

Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.

Richelsen B, Tonstad S, Rössner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A.

Diabetes Care. 2007 Jan;30(1):27-32.PMID: 17192328 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S.

Diabetes Care. 2002 Jul;25(7):1123-8. Erratum in: Diabetes Care. 2002 Sep;25(9):1671.. PMID: 12087008 [PubMed - indexed for MEDLINE]Related articlesFree article

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.

Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D, Heimburger DC, Lucas CP, Robbins DC, Chung J, Heymsfield SB.

JAMA. 1999 Jan 20;281(3):235-42. Erratum in: JAMA 1999 Apr 7;281(13):1174. PMID: 9918478 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study.

Lindgärde F.

J Intern Med. 2000 Sep;248(3):245-54.PMID: 10971792 [PubMed - indexed for MEDLINE]Related articles

Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.

Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J.

JAMA. 2005 Jun 15;293(23):2873-83. Erratum in: JAMA. 2005 Sep 28;294(12):1491. PMID: 15956632 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M.

Lancet. 1998 Jul 18;352(9123):167-72.PMID: 9683204 [PubMed - indexed for MEDLINE]Related articles

Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial.

Anderson JW, Schwartz SM, Hauptman J, Boldrin M, Rossi M, Bansal V, Hale CA.

Ann Pharmacother. 2006 Oct;40(10):1717-23. Epub 2006 Aug 29.PMID: 16940406 [PubMed - indexed for MEDLINE]Related articles

Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns.

Karhunen L, Franssila-Kallunki A, Rissanen P, Valve R, Kolehmainen M, Rissanen A, Uusitupa M.

Int J Obes Relat Metab Disord. 2000 Dec;24(12):1567-72.PMID: 11126207 [PubMed - indexed for MEDLINE]Related articles

The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial.

Hanefeld M, Sachse G.

Diabetes Obes Metab. 2002 Nov;4(6):415-23.PMID: 12406041 [PubMed - indexed for MEDLINE]Related articles

Treatment with orlistat reduces cardiovascular risk in obese patients.

Zavoral JH.

J Hypertens. 1998 Dec;16(12 Pt 2):2013-7.PMID: 9886891 [PubMed - indexed for MEDLINE]Related articles